SBRT-induced upregulation of MHC molecules in in vitro BC models, together with the boosting of T cell responses in oligometastatic BC patients after SBRT, prompted us to evaluate whether PBMCs collected from patients before and after SBRT exerted different ability to recognize untreated or irradiated BC cell lines. This evidence concerns the gene HLA-C and breast cancer.